MARKET

VICP

VICP

Vicapsys Life Sc
OTCPK
2.450
+0.400
+19.51%
Closed 09:32 03/14 EDT
OPEN
2.450
PREV CLOSE
2.050
HIGH
2.450
LOW
2.450
VOLUME
100
TURNOVER
245
52 WEEK HIGH
14.00
52 WEEK LOW
0.440
MARKET CAP
79.31M
P/E (TTM)
-61.7128
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at VICP last week (0303-0307)?
Weekly Report · 6d ago
Weekly Report: what happened at VICP last week (0224-0228)?
Weekly Report · 03/03 09:32
Weekly Report: what happened at VICP last week (0217-0221)?
Weekly Report · 02/24 09:32
Weekly Report: what happened at VICP last week (0210-0214)?
Weekly Report · 02/17 09:31
Weekly Report: what happened at VICP last week (0203-0207)?
Weekly Report · 02/10 09:30
Weekly Report: what happened at VICP last week (0127-0131)?
Weekly Report · 02/03 09:31
Weekly Report: what happened at VICP last week (0120-0124)?
Weekly Report · 01/27 09:31
Weekly Report: what happened at VICP last week (0113-0117)?
Weekly Report · 01/20 09:30
More
About VICP
Vicapsys Life Sciences, Inc. develops and commercializes, on a worldwide basis, various intellectual property rights relating to a series of encapsulated products that incorporate proprietary derivatives of the chemokine CXCL12 for creating a zone of immunoprotection around cells, tissues, organs and devices for therapeutic purposes. VICAPSYN is the Company’s product line that is applied to transplantation therapies and related stem-cell applications in the transplantation field. The lead product candidate embodiment in transplantation therapy to treat Type 1 Diabetes (T1D) is an encapsulated human islet cell cluster that is intended to restore normal glucose control when implanted into the peritoneal cavity of a patient. It also develops another product candidate line based on CXCL12 with the trade name of VYBRIN. The clinical applications of VYBRIN are being explored in several areas, including prevention of post-surgical adhesions in abdominal surgery and others.

Webull offers Vicapsys Life Sciences Inc stock information, including OTCPK: VICP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VICP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VICP stock methods without spending real money on the virtual paper trading platform.